Vaill Covitrap (Human IgG1 anti-SARS-CoV-2 antibody cocktail)
/ Hibiocy, Chulalongkorn University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 07, 2022
Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: Chulalongkorn University | Recruiting ➔ Completed | N=300 ➔ 50
Enrollment change • Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
May 03, 2022
Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-SARS-CoV-2 Antibody Cocktail
(clinicaltrials.gov)
- P1 | N=300 | Recruiting | Sponsor: Chulalongkorn University
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1